Fountain Valley, California 92708

  • Psoriasis

Purpose:

The main purpose of this study is to characterize the long-term safety and efficacy of the drug BMS-986165 in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.


Criteria:

Inclusion Criteria: - Completion of the protocol-required treatment period in an applicable study of BMS-986165 in moderate-to-severe psoriasis - Women must not be pregnant, lactating, or breastfeeding Exclusion Criteria: - Any disease or medical condition that the investigator feels that would make the patient unsuitable for this study. - To be eligible for the study, a participant must not have active signs or symptoms of tuberculosis (TB) as judged by the investigator.


NCT ID:

NCT04036435


Primary Contact:

Rachel Peterson
Phone: +1 619 293 6213
Email: PetersonRachel@prahs.com


Backup Contact:

N/A


Location Contact:

Fountain Valley, California 92708
United States

Vivian Laquer, Site 0046
Phone: 714-531-2966

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 28, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.